BioSpace News Archive

Press Releases

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

October 15, 2024
·
4 min read
Press Releases

Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting

October 15, 2024
·
2 min read
Press Releases

Transpire Bio Strengthens Leadership Team with New Appointments to Lead Commercialization, Quality Assurance, and Manufacturing

October 15, 2024
·
2 min read
Press Releases

Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer

October 15, 2024
·
6 min read
Press Releases

Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024

October 15, 2024
·
4 min read
Press Releases

CervoMed Announces Last Patient Last Visit in Phase 2b RewinD-LB Trial of Neflamapimod for the Treatment of Early-Stage Dementia with Lewy Bodies (DLB)

October 15, 2024
·
6 min read
Press Releases

Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger

October 15, 2024
·
13 min read
Press Releases

Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial

October 15, 2024
·
4 min read
Press Releases

RTI International and Codetta Bio™ announce strategic collaboration to accelerate healthcare innovation

October 15, 2024
·
3 min read
Press Releases

Aligos Therapeutics Announces Acceptance of Abstracts on Incremental Data from ALG-000184 in CHB Subjects and Late-Breaker Oral Presentation of Data from the Phase 2a HERALD Study of ALG-055009 in MASH Subjects at The Liver Meeting (TLM) 2024

October 15, 2024
·
4 min read